320749-20-0

Basic information

• Product Name: 5-(benzyloxy)pent-1-en-3-one
• Synonyms: 5-(benzyloxy)pent-1-en-3-one
• CAS NO: 320749-20-0
• Molecular Weight: 190.242
• Mol File: 320749-20-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-(benzyloxy)pent-1-en-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(benzyloxy)pent-1-en-3-one(320749-20-0)
• EPA Substance Registry System: 5-(benzyloxy)pent-1-en-3-one(320749-20-0)

Safety Data

• Hazardous Substances Data: 320749-20-0(Hazardous Substances Data)

Upstream product

• 100-44-7 benzyl chloride 
• 4799-68-2 3-benzyloxypropan-1-ol 
• 100-39-0 benzyl bromide 
• 81518-74-3 1-benzyloxy-4-pentene 
• 117661-29-7 5-(benzyloxy)pent-1-en-3-ol 

Downstream Products

• 320749-22-2 5-benzyloxy-3-[(2H₃)methyl]-4-pentan-1,3-diol 
• 61219-76-9 RS-Mevalonolactone-6,6,6-2H3 
• 320749-21-1 1-benzyloxy-3-[(2H₃)methyl]-4-penten-3-ol 

Relevant articles and documents

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

The present invention relates to C-20 steroid compounds, compositions and methods of use thereof to treat, minimize and/or prevent traumatic brain injury (TBI), including severe TBI, moderate TBI and mild TBI, including concussions.

C-20 STEROID COMPOUNDS, COMPOSITIONS, AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

The present invention relates to C-20 steroid compounds, compositions and methods of use thereof to treat, minimize and/or prevent traumatic brain injury (TBI), including severe TBI, moderate TBI and mild TBI, including concussions.

Practical synthesis of [3-(2H3)methyl]mevalonolactone and incorporation experiment of [3-(2H3)methyl]mevalonolactone and [13C]labeled acetate in the biosynthesis of isoprenoidal diether lipids of halophilic archaea

The biosynthesis of the saturated isoprenoid portion of membrane lipids of the halophilic archaea Natrinema pallidum was investigated. At first, a practical method for the synthesis of [3-(2H3)methyl]mevalonate was developed. Then, incorporation experiments of [3-(2H3)methyl]mevalonate into the lipid core indicated that the isoprenoid portion was derived from mevalonate. However, a [2-13C]acetate-incorporation experiment revealed a significant difference in the degree of 13C enrichment between the expected position from the mevalonate pathway, the CH2 groups (and at one terminal CH3 group) and the CH3 groups in the saturated isoprenoid chain. These results suggest that (1) the mevalonate pathway exists and is active, and (2) a part of acetoacetyl-CoA is not derived from an acetate in the biosynthesis of the isoprenoidal lipid-core of the archaebacterium.